NEWS COMMENTARY

Company that provides erectile dysfunction prescriptions via telemedicine offers COVID-19 assessments – despite appearances, a good thing

Published:
March 13, 2020
Coverage:
Digital Transformation More...
Activities:
Product
by Danielle Bradnan
Very important

Roman's service has been called into question due to its primary offering of erectile dysfunction prescriptions. Ro is leveraging its existing infrastructure to provide the current best practices of medical care (especially given the absence of available tests) via a nontraditional subscription service. However, it does highlight the fact that patients are left hanging by insurance providers that don't reimburse for telemedicine services. The arrival of COVID-19 should be a wake-up call for the need for reimbursed telehealth services, and a failure to acknowledge this need risks disruption of the healthcare industry by up-and-coming subscription models.

For the original news article, click here .